Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

MustGrow expands product line with three new biological solutions

MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has introduced three new biological products to its Canadian lineup following its acquisition of sales and distribution division NexusBioAg, the company said on Tuesday.

The additions—EZ-Gro Max, EZ-Gro Cyto, and Rootella mycorrhizal inoculants—are designed to enhance crop health, increase yield potential, and improve resilience against environmental stress, MustGrow said in a statement.

"With this new product lineup, we are offering Canadian farmers proven, science-driven products that support sustainable farming while delivering strong agronomic performance," said Colin Bletsky, MustGrow’s chief operating officer.

EZ-Gro Max, a biostimulant powered by Bio-APP Technology, aims to improve plant growth and foliar nutrition while mitigating environmental stress.

EZ-Gro Cyto is formulated to help crops endure extreme conditions such as drought, heat, and salinity.

Rootella, developed by Groundwork BioAg, enhances root networks for better water and nutrient absorption.

Saskatoon-based MustGrow closed the acquisition of NexusBioAg’s assets from Univar Solutions Canada Ltd in January 2025, giving the company a Canadian sales, marketing, and distribution division, with plans to expand operations into the United States.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK